Optogenetic Protein Therapy for Multiple Sclerosis

Project Information

OPTOGENERAPY

Grant agreement ID: 720694

DOI 10.3030/720694

Project closed

EC signature date 23 November 2016

Start date 1 January 2017

End date 31 January 2020

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials

Total cost € 6 233 257,50

EU contribution € 4 777 257,50

Coordinated by

FUNDACIO EURECAT
Spain

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Websites, patent fillings, videos etc. (2)

Final communication materials

Final collection of public materials prepared for communication purposes.

Public communication materials

First collection of public materials prepared for communication purposes.

Publications

Peer reviewed articles (1)

From Photoilumination to Optogenerapy, Recent Advances in NIR LightPhotomedicine Applications

Author(s): Vanessa Pierroz and Marc Folcher
Published in: J Mol Genet Med, Issue Vol.2 No.1:10, 2018
Publisher: iMedPub Journals

Non-peer reviewed articles (1)

Optogenerapy: When bio-electronic implant enters the modern syringe era

Author(s): Fanny Michel, Marc Folcher
Published in: Porto Biomedical Journal, Issue 2/5, 2017, Page(s) 145-149, ISSN 2444-8664
Publisher: Elsevier Espana, S.L.U
DOI: 10.1016/j.pbj.2017.07.001